logo

Sesen Bio Inc (SESN)



Trade SESN now with
  Date
  Headline
8/10/2020 7:49:16 AM Sesen Bio Q2 Net Loss $26.3 Mln Or $0.24/Shr Vs Net Loss Of $54.3 Mln Or $0.67/Shr Last Year
7/31/2020 7:38:12 AM Sesen Bio Announces Agreement With Qilu For Development And Commercialization Of Vicineum In China
5/11/2020 7:13:48 AM Sesen Bio Q1 Net Income $41.6 Mln Or $0.31/Shr Vs Loss Of $6.5 Mln Or $0.08/Shr Last Year
3/16/2020 7:15:21 AM Sesen Bio Q4 Net Loss Widens To $33.6 Mln From $6.8 Mln Last Year
12/9/2019 7:32:51 AM Sesen Bio Initiates Rolling Submission Of BLA For Vicinium To FDA
11/12/2019 7:14:33 AM Sesen Bio Q3 Net Loss $13.1 Mln Or $0.13/Shr Vs Loss $14.0 Mln Or $0.18/Shr Last Year
6/19/2019 8:17:31 AM Sesen Bio Reports Pricing Of Public Offering Of 20.4 Mln Shares Of Common Stock And Warrants
1/3/2019 6:33:24 AM Sesen Bio Announces Positive Preliminary 12-Month Data From Registration Phase 3 VISTA Trial Of Vicinium For NMIBC
12/26/2018 12:40:01 AM 8 Biotech Stocks To Watch This Week
12/3/2018 6:30:52 AM Sesen Bio Appoints Dennis Kim As Chief Medical Officer
8/14/2018 6:33:49 AM Sesen Bio Q2 Net Loss $9.0 Mln Or $0.16/Shr Vs Loss $7.3 Mln Or $0.30/Shr Last Year
8/9/2018 6:32:03 AM Sesen Bio Says FDA Granted Fast Track Designation To Vicinium